Investigation of SEN virus prevalence in hemophilia patients

Background: Hemophilia and transfusion-dependent patients are at high risk of a wide range of blood-borne agents. Among these, SEN virus (SENV) stands out as a significant concern due to its association with transfusion-induced non-A to non-E hepatitis. This study, therefore, aimed to investigate th...

Full description

Saved in:
Bibliographic Details
Main Authors: Davod Javanmard, Motahareh Mahi-Birjand, Effat Alemzadeh, Mahdie Mohammadi, Masood Ziaee
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:New Microbes and New Infections
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2052297524002543
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850108412997664768
author Davod Javanmard
Motahareh Mahi-Birjand
Effat Alemzadeh
Mahdie Mohammadi
Masood Ziaee
author_facet Davod Javanmard
Motahareh Mahi-Birjand
Effat Alemzadeh
Mahdie Mohammadi
Masood Ziaee
author_sort Davod Javanmard
collection DOAJ
description Background: Hemophilia and transfusion-dependent patients are at high risk of a wide range of blood-borne agents. Among these, SEN virus (SENV) stands out as a significant concern due to its association with transfusion-induced non-A to non-E hepatitis. This study, therefore, aimed to investigate the prevalence of this virus in hemophilia patients, focusing on potential complications and risk factors. Method: This was a cross-sectional study conducted in a hemophilia center in the east of Iran. Blood samples were taken from patients and healthy people, and demographic and clinical information was collected. The sera samples were then subjected to DNA extraction. PCR-based methods detected SENV and its genotype, and then phylogenetic analysis was performed. The collected data were analyzed and interpreted by SPSS22 software. Results: The mean age of patients and the healthy group was 26.18 ± 14.97 and 41.69 ± 14.05, respectively. Among the patient and healthy groups, 94.5 % and 36.4 % were male, and the rest were female, respectively. Most of the participants in the patient group had hemophilia type A (85.5 %), then type B (7.3 %), VWD type (3.6 %), and F and plt type (1.8 %) were in the next categories. SENV-DNA was detected in 58.2 % of patients and 20 % of healthy groups (P-value: 0.00). Among these, H and D genotypes were found in 35 % and 23.7 % of patients and 12.7 % and 7.3 % of healthy groups, respectively. The prevalence of the virus was significantly related to minor elevation of AST and was higher in hemophilia type A (63.8 %) and severe type of disease (63.2 %). Conclusion: This study underscore the significant prevalence of the SENV virus in hemophilia patients, a particularly noteworthy finding compared to the healthy population. With the limited information available about this virus, our findings highlight the importance of continuous monitoring and follow-up of high-risk groups in relation to blood-borne pathogens, providing reassurance about the ongoing efforts in the field.
format Article
id doaj-art-a79ca14328f64f1eaa49d8dc52b1f326
institution OA Journals
issn 2052-2975
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series New Microbes and New Infections
spelling doaj-art-a79ca14328f64f1eaa49d8dc52b1f3262025-08-20T02:38:22ZengElsevierNew Microbes and New Infections2052-29752024-12-016210147010.1016/j.nmni.2024.101470Investigation of SEN virus prevalence in hemophilia patientsDavod Javanmard0Motahareh Mahi-Birjand1Effat Alemzadeh2Mahdie Mohammadi3Masood Ziaee4Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, IranDepartment of Clinical Pharmacy, School of Pharmacy, Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, IranInfectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, IranStudent Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, IranInfectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran; Corresponding author.Background: Hemophilia and transfusion-dependent patients are at high risk of a wide range of blood-borne agents. Among these, SEN virus (SENV) stands out as a significant concern due to its association with transfusion-induced non-A to non-E hepatitis. This study, therefore, aimed to investigate the prevalence of this virus in hemophilia patients, focusing on potential complications and risk factors. Method: This was a cross-sectional study conducted in a hemophilia center in the east of Iran. Blood samples were taken from patients and healthy people, and demographic and clinical information was collected. The sera samples were then subjected to DNA extraction. PCR-based methods detected SENV and its genotype, and then phylogenetic analysis was performed. The collected data were analyzed and interpreted by SPSS22 software. Results: The mean age of patients and the healthy group was 26.18 ± 14.97 and 41.69 ± 14.05, respectively. Among the patient and healthy groups, 94.5 % and 36.4 % were male, and the rest were female, respectively. Most of the participants in the patient group had hemophilia type A (85.5 %), then type B (7.3 %), VWD type (3.6 %), and F and plt type (1.8 %) were in the next categories. SENV-DNA was detected in 58.2 % of patients and 20 % of healthy groups (P-value: 0.00). Among these, H and D genotypes were found in 35 % and 23.7 % of patients and 12.7 % and 7.3 % of healthy groups, respectively. The prevalence of the virus was significantly related to minor elevation of AST and was higher in hemophilia type A (63.8 %) and severe type of disease (63.2 %). Conclusion: This study underscore the significant prevalence of the SENV virus in hemophilia patients, a particularly noteworthy finding compared to the healthy population. With the limited information available about this virus, our findings highlight the importance of continuous monitoring and follow-up of high-risk groups in relation to blood-borne pathogens, providing reassurance about the ongoing efforts in the field.http://www.sciencedirect.com/science/article/pii/S2052297524002543HemophiliaSEN virusSENVPrevalenceGenotypePhylogeny
spellingShingle Davod Javanmard
Motahareh Mahi-Birjand
Effat Alemzadeh
Mahdie Mohammadi
Masood Ziaee
Investigation of SEN virus prevalence in hemophilia patients
New Microbes and New Infections
Hemophilia
SEN virus
SENV
Prevalence
Genotype
Phylogeny
title Investigation of SEN virus prevalence in hemophilia patients
title_full Investigation of SEN virus prevalence in hemophilia patients
title_fullStr Investigation of SEN virus prevalence in hemophilia patients
title_full_unstemmed Investigation of SEN virus prevalence in hemophilia patients
title_short Investigation of SEN virus prevalence in hemophilia patients
title_sort investigation of sen virus prevalence in hemophilia patients
topic Hemophilia
SEN virus
SENV
Prevalence
Genotype
Phylogeny
url http://www.sciencedirect.com/science/article/pii/S2052297524002543
work_keys_str_mv AT davodjavanmard investigationofsenvirusprevalenceinhemophiliapatients
AT motaharehmahibirjand investigationofsenvirusprevalenceinhemophiliapatients
AT effatalemzadeh investigationofsenvirusprevalenceinhemophiliapatients
AT mahdiemohammadi investigationofsenvirusprevalenceinhemophiliapatients
AT masoodziaee investigationofsenvirusprevalenceinhemophiliapatients